Pay in 4 interest-free payments of $6.83 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
Why do so many people stop taking them after only a few months
In MOUNJARO placebo-controlled clinical trials, acute gallbladder disease (cholelithiasis, biliary colic, and cholecystectomy) was reported by 0.6% of MOUNJARO-treated patients and 0% of placebo-treated patients
What this means for your daytoday Semaglutide sends a single GLP1 signal that slows stomach emptying, improves postmeal insulin response, and tells your brain you have had enough, which usually shows up as fewer cravings and smaller meals feeling satisfying. Tirzepatide layers GIP on top of GLP1, so you see similar appetite and gastricemptying effects plus extra help with insulin and lipid handling, which often translates into a deeper drop in hunger and faster, larger changes on the scale and in labs
While the body is designed to manage these changes, the "drain" on your natural antioxidant stores can be significant
Common side effects Nausea Diarrhea or constipation Vomiting Abdominal pain Decreased appetite Serious risks Pancreatitis (inflammation of the pancreas) Gallbladder problems Low blood sugar, especially with other diabetes medicines Kidney problems related to dehydration Serious allergic reactions Do not use if you have Personal or family history of medullary thyroid carcinoma Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) Known serious allergy to tirzepatide Pregnancy or breastfeeding How it compares Frequently asked questions What is compounded tirzepatide
